Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Finerenone Research of Outcomes and Drug Utilization

NCT06278207 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT06278207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06278207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Finerenone Research of Outcomes and Drug Utilization
Lead sponsor
Bayer
Phase
Observational
Overall status
Recruiting
Start date
May 15, 2024
Completion date
September 30, 2026
Enrollment
50,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, type 2 diabetes mellitus